Delivery Order SPE2DB24D1205-SPE2DB25FDATK
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order carries a ceiling value of $71,179.72 and is scheduled for ultimate completion by May 13, 2025. The award was made through open competition with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 16, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed-price contract with a ceiling value of $1,797.10 and an ultimate completion date of July 17, 2025. The award was made through open competition with no set-aside designation. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $9,921.90, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 15, 2025. The contract will be performed at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60-tablet packages. This firm fixed-price delivery order, valued at $39,593.14, is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,931.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. The place of performance is listed as Conshohocken, PA, and the delivery order is scheduled...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 2.5 mg tablets in a 60-count package configuration. This firm fixed-price delivery order carries a ceiling value of $3,931.20 and is scheduled for completion by September 15, 2025. The award was made through open competition with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,042.22 by the Defense Logistics Agency (DLA) on August 12, 2025, with an ultimate completion date of August 13, 2025. The award is for the supply of Eliquis 5 mg tablets (60-count units), an anticoagulant medication commonly used in military and federal healthcare systems. This is a firm fixed price delivery order with no set-aside designation,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $24,277.88. This firm fixed-price delivery order, which concludes on August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal healthcare...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDATKDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $32,285.78. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. This delivery order supports the Defense Health Agency and broader military medical supply chain requirements by providing a commonly prescribed anticoagulant medication. AmerisourceBergen's portfolio of federal contracts demonstrates extensive capability in delivering a wide range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The competitively awarded delivery orders consistently employ firm fixed pricing and reflect the company's established role as a critical vendor for federal medical procurement, particularly within the military healthcare system's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 9/22/25 |